Signal Detection of Potentially Drug-Induced Acute Liver Injury in Children Using a Multi-Country Healthcare Database Network-Reference-Cited by-同舟云学术

Signal Detection of Potentially Drug-Induced Acute Liver Injury in Children Using a Multi-Country Healthcare Database Network

Published:2014-01-21 Issue:2 Volume:37 Page:99-108
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

Ferrajolo Carmen, ,Coloma Preciosa M.,Verhamme Katia M. C.,Schuemie Martijn J.,de Bie Sandra,Gini Rosa,Herings Ron,Mazzaglia Giampiero,Picelli Gino,Giaquinto Carlo,Scotti Lorenza,Avillach Paul,Pedersen Lars,Rossi Francesco,Capuano Annalisa,van der Lei Johan,Trifiró Gianluca,Sturkenboom Miriam C. J. M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Link

http://link.springer.com/content/pdf/10.1007/s40264-013-0132-9.pdf

Reference36 articles.

1. Ferrajolo C, Capuano A, Verhamme KM, Schuemie M, Rossi F, Stricker BH, et al. Drug-induced hepatic injury in children: a case/non-case study of suspected adverse drug reactions in VigiBase. Br J Clin Pharmacol. 2010;70(5):721–8.

2. Stephenson WP, Hauben M. Data mining for signals in spontaneous reporting databases: proceed with caution. Pharmacoepidemiol Drug Saf. 2007;16(4):359–65.

3. Coloma PM, Avillach P, Salvo F, Schuemie MJ, Ferrajolo C, Pariente A, et al. A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases. Drug Saf. 2013;36(1):13–23.

4. Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol. 2005;58(4):323–37.

5. Platt R, Wilson M, Chan KA, Benner JS, Marchibroda J, McClellan M. The new Sentinel Network—improving the evidence of medical-product safety. N Engl J Med. 2009;361(7):645–7.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of Electronic Health Record Data for Drug Safety Signal Identification: A Scoping Review;Drug Safety;2023-06-20

2. An industry perspective on the use of machine learning in drug and vaccine safety;Frontiers in Drug Safety and Regulation;2023-02-01

3. Pharmacovigilance of Innovator Biologics and Biosimilars;Biologics, Biosimilars, and Biobetters;2020-12-30

4. Electronic Medical Records and Machine Learning in Approaches to Drug Development;Artificial Intelligence in Oncology Drug Discovery and Development;2020-09-09

5. From Animal Poisons and Venoms to Medicines: Achievements, Challenges and Perspectives in Drug Discovery;Frontiers in Pharmacology;2020-07-24